Haihao J. Li

Kunming, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Commentary: Characteristics of tertiary lymphoid structures in prostate cancer and the impact of neoadjuvant therapy on their formation and maturation.

Commentary: Characteristics of tertiary lymphoid structures in prostate cancer and the impact of neoadjuvant therapy on their formation and maturation.

Journal: Frontiers in immunology

Published: July 01, 2026

Targeting the extracellular vesicle-immune axis in prostate cancer: mechanisms of immune evasion and emerging therapeutic strategies.

Targeting the extracellular vesicle-immune axis in prostate cancer: mechanisms of immune evasion and emerging therapeutic strategies.

Journal: Biochemical pharmacology

Published: June 19, 2026

Case Report: Clinicopathological features of bladder neuroendocrine neoplasm: a retrospective case series of nine cases and literature review.

Case Report: Clinicopathological features of bladder neuroendocrine neoplasm: a retrospective case series of nine cases and literature review.

Journal: Frontiers in oncology

Published: April 10, 2026

Engineering Multimodal Nanomaterials for Prostate Cancer Theranostics: Design Principles, Recent Advances, and Translational Challenges.

Engineering Multimodal Nanomaterials for Prostate Cancer Theranostics: Design Principles, Recent Advances, and Translational Challenges.

Journal: International journal of nanomedicine

Published: April 08, 2026

The Application of Nanomaterials in Kidney Stone Disease: Emerging Strategies for Early Diagnosis, Targeted Therapy, and Prevention.

The Application of Nanomaterials in Kidney Stone Disease: Emerging Strategies for Early Diagnosis, Targeted Therapy, and Prevention.

Journal: International journal of nanomedicine

Published: March 20, 2026

Integrative multi-omics analysis identifies key ubiquitination regulators in prostate cancer.

Integrative multi-omics analysis identifies key ubiquitination regulators in prostate cancer.

Journal: Translational oncology

Published: January 30, 2026

Construction of a gene-metabolite-microbiome regulatory network reveals novel therapeutic targets in bladder cancer through multi-omics analysis.

Construction of a gene-metabolite-microbiome regulatory network reveals novel therapeutic targets in bladder cancer through multi-omics analysis.

Journal: Annals of medicine

Published: September 05, 2025

Causal association analysis between 731 immune cells and cystitis: A 2-sample, bidirectional Mendelian randomization study.

Causal association analysis between 731 immune cells and cystitis: A 2-sample, bidirectional Mendelian randomization study.

Journal: Medicine

Published: May 10, 2025

Silencing CALB1 enhances prostate cancer radiosensitivity via calcium-mediated mitochondrial dysfunction and cellular senescence.

Silencing CALB1 enhances prostate cancer radiosensitivity via calcium-mediated mitochondrial dysfunction and cellular senescence.

Journal: Cell calcium

Published: April 29, 2025

Lymphadenectomy in upper tract urothelial carcinoma: Clinical insights and controversies (Review).

Lymphadenectomy in upper tract urothelial carcinoma: Clinical insights and controversies (Review).

Journal: Oncology reports

Published: March 29, 2025

Potential of APOBEC3B as a therapeutic target and its role in bladder cancer onset and progression.

Potential of APOBEC3B as a therapeutic target and its role in bladder cancer onset and progression.

Journal: European journal of medical research

Published: March 11, 2025

Machine Learning and Experimental Validation Reveal MYH11 as a Novel Prognostic Biomarker and Therapeutic Target in Bladder Cancer.

Machine Learning and Experimental Validation Reveal MYH11 as a Novel Prognostic Biomarker and Therapeutic Target in Bladder Cancer.

Journal: Journal of inflammation research

Published: February 16, 2025

Showing 1-12 of 27

Last Updated: 09/26/2026